CC
TAK icon

Callan Capital’s Takeda Pharmaceutical TAK Stock Holding History

Callan Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$735K Buy
+49,425
New +$693K 0.05% 152
2024
Q2 		– Sell
-25,461
Closed -$354K – 329
2024
Q1 		$354K Buy
25,461
+12,010
+89% +$175K 0.03% 179
2023
Q4 		$192K Buy
+13,451
New +$191K 0.02% 216

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Callan Capital's TAK Position: Q1 2025 in Review

Callan Capital opened a new position in Takeda Pharmaceutical (TAK) in Q1 2025: 49,425 shares worth $735K. The stake represents 0.05% of the portfolio and ranks #152 among its holdings. This is a return to the name: Callan Capital previously reported a position in TAK as recently as Q1 2024.

Callan Capital first reported a position in TAK in Q4 2023 and has held it in 3 quarters since. 307 funds tracked by Wall St. Rank hold TAK as of Q1 2025.

  • Callan Capital held 49,425 shares of Takeda Pharmaceutical worth $735K as of Q1 2025.
  • Takeda Pharmaceutical was a new Callan Capital position in Q1 2025.
  • Takeda Pharmaceutical made up 0.05% of Callan Capital's portfolio in Q1 2025, its #152 holding.
  • Callan Capital first reported a position in Takeda Pharmaceutical in Q4 2023 and has held it in 3 quarters since.
  • 307 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.